The cancer cells expressed L1CAM (CD171) and EPCAM (CD326), which are prognostic/diagnostic biomarkers often overexpressed on cancer cells, with roles in supporting cell motility, invasion, proliferation, and metastatic progression (Altevogt et al., 2016; Gires et al., 2020). Here, EPCAM is linked to cancer.